Investing: Should you invest in ISIS? (They are doing "better than expected")
--> (Lynk)
Business Profile:
Business Summary Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The companys flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia; and for the reduction of low-density lipoprotein cholesterol. It also has a pipeline of 38 drugs in development for the treatment of various diseases, including cardiovascular and metabolic diseases; severe and rare diseases, which include neurological disorders; and cancer. The company has strategic alliances and collaboration agreements primarily with AstraZeneca AB, Biogen Idec MA Inc., Bristol-Myers Squibb, Eli Lilly and Company, Genzyme Corporation, Hoffman-La Roche Inc., F. Hoffmann-La Roche Ltd., Alnylam Pharmaceuticals, Inc., Antisense Therapeutics Limited, Excaliard Pharmaceuticals, Inc., OncoGenex Technologies Inc., Janssen Biotech, Inc., and Atlantic Pharmaceuticals Limited. Isis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, California.
Tags
Who is online
408 visitors
Full disclosure: I do not own shares of ISIS stock nor do I inten to buy any within the next 60 days. Or ever . . .
Saw an interview with the CEO a few months back. They asked him if they'd be changing their name because of the terrorist organization of the same name.
He replied, "No, let them change their name."
Heh
A about that time I had seen a newspaper article a few companies with the name "ISIS". One was a grocery store, ...there were others. A real annoyance, plus an unnecessary expense.